Citation tools
"A Promising Therapeutic Approach for Multiple Sclerosis: Recombinant T-Cell Receptor Ligands Modulate Experimental Autoimmune Encephalomyelitis by Reducing Interleukin-17 Production and Inhibiting Migration of Encephalitogenic Cells into the CNS." Journal of Neuroscience
27.46
(2007):
12531-12539.
Web. 17 April. 2024.